End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2787 USD | -0.78% | -9.37% | -57.77% |
03-21 | Senti Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-21 | Earnings Flash (SNTI) SENTI BIOSCIENCES Reports 2023 Revenue $2.6M | MT |
Sales 2022 | 4.29M 5.86M | Sales 2023 | 2.56M 3.5M | Capitalization | 29.4M 40.19M |
---|---|---|---|---|---|
Net income 2022 | -58M -79.28M | Net income 2023 | -71M -97.05M | EV / Sales 2022 | -0.25 x |
Net cash position 2022 | 62.89M 85.96M | Net Debt 2023 | 1.7M 2.32M | EV / Sales 2023 | 12.1 x |
P/E ratio 2022 |
-0.63
x | P/E ratio 2023 |
-0.41
x | Employees | 48 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
1 day | -0.78% | ||
1 week | -9.37% | ||
Current month | -26.09% | ||
1 month | -32.35% | ||
3 months | -36.51% | ||
6 months | -4.85% | ||
Current year | -57.77% |
Managers | Title | Age | Since |
---|---|---|---|
Timothy Lu
FOU | Founder | 43 | 16-06-08 |
Director of Finance/CFO | 51 | 21-04-30 | |
Kanya Rajangam
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Berland
BRD | Director/Board Member | 69 | 21-05-31 |
Director/Board Member | 64 | 16-06-30 | |
Omid Farokhzad
BRD | Director/Board Member | 55 | 22-06-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.18% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.29 | +4.05% | 44,490 |
24-04-25 | 0.2787 | -0.78% | 31,770 |
24-04-24 | 0.2809 | -6.37% | 51,554 |
24-04-23 | 0.3 | +6.80% | 20,031 |
24-04-22 | 0.2809 | -8.65% | 92,848 |
End-of-day quote Nasdaq, April 24, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-57.77% | 13.27M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SNTI Stock